These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 36065928)

  • 21. Nanoparticles as phytochemical carriers for cancer treatment: News of the last decade.
    Melim C; Magalhães M; Santos AC; Campos EJ; Cabral C
    Expert Opin Drug Deliv; 2022 Feb; 19(2):179-197. PubMed ID: 35166619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment.
    Choukaife H; Seyam S; Alallam B; Doolaanea AA; Alfatama M
    Int J Nanomedicine; 2022; 17():3933-3966. PubMed ID: 36105620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted Delivery of Drugs and Genes Using Polymer Nanocarriers for Cancer Therapy.
    Xia W; Tao Z; Zhu B; Zhang W; Liu C; Chen S; Song M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanotechnology for the delivery of phytochemicals in cancer therapy.
    Xie J; Yang Z; Zhou C; Zhu J; Lee RJ; Teng L
    Biotechnol Adv; 2016; 34(4):343-353. PubMed ID: 27071534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic strategies to overcome taxane resistance in cancer.
    Das T; Anand U; Pandey SK; Ashby CR; Assaraf YG; Chen ZS; Dey A
    Drug Resist Updat; 2021 Mar; 55():100754. PubMed ID: 33691261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical application of nano-targeting for enhancing chemotherapeutic efficacy and safety in cancer management.
    Phillips MC; Mousa SA
    Nanomedicine (Lond); 2022 Mar; 17(6):405-421. PubMed ID: 35118878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanosponges Encapsulated Phytochemicals for Targeting Cancer: A Review.
    Dombe S; Shirote P
    Curr Drug Targets; 2021; 22(4):443-462. PubMed ID: 33045959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advancements in the targeted delivery of etoposide nanomedicine for cancer therapy: A comprehensive review.
    Fathi-Karkan S; Arshad R; Rahdar A; Ramezani A; Behzadmehr R; Ghotekar S; Pandey S
    Eur J Med Chem; 2023 Nov; 259():115676. PubMed ID: 37499287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Most Recent Discoveries in Heterocyclic Nanoformulations for Targeted Anticancer Therapy.
    Bhattacharya S; Patel R; Joshi A
    Mini Rev Med Chem; 2022; 22(13):1735-1751. PubMed ID: 35114919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanoformulations of Plant-Derived Compounds as Emerging Therapeutic Approach for Colorectal Cancer.
    Biganeh H; Dizaji SM; Taghipour YD; Murtaza G; Rahimi R
    Curr Drug Deliv; 2023; 20(8):1067-1094. PubMed ID: 36017863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting Cancer Via Resveratrol-Loaded Nanoparticles Administration: Focusing on In Vivo Evidence.
    Santos AC; Pereira I; Magalhães M; Pereira-Silva M; Caldas M; Ferreira L; Figueiras A; Ribeiro AJ; Veiga F
    AAPS J; 2019 Apr; 21(4):57. PubMed ID: 31016543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.
    Li L; Xiang D; Shigdar S; Yang W; Li Q; Lin J; Liu K; Duan W
    Int J Nanomedicine; 2014; 9():1083-96. PubMed ID: 24591829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phyto-drug conjugated nanomaterials enhance apoptotic activity in cancer.
    Vimala K; Kannan S
    Adv Protein Chem Struct Biol; 2021; 125():275-305. PubMed ID: 33931143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A critical review of lipid-based nanoparticles for taxane delivery.
    Feng L; Mumper RJ
    Cancer Lett; 2013 Jul; 334(2):157-75. PubMed ID: 22796606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanomedicine as a Strategy for Natural Compound Delivery to Prevent and Treat Cancers.
    Aljuffali IA; Fang CL; Chen CH; Fang JY
    Curr Pharm Des; 2016; 22(27):4219-31. PubMed ID: 27323758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loading studies of the anticancer drug camptothecin into dual stimuli-sensitive nanoparticles. Stability scrutiny.
    Iglesias N; Galbis E; Díaz-Blanco MJ; de-Paz MV; Galbis JA
    Int J Pharm; 2018 Oct; 550(1-2):429-438. PubMed ID: 30196142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Redox-responsive nano-carriers as tumor-targeted drug delivery systems.
    Raza A; Hayat U; Rasheed T; Bilal M; Iqbal HMN
    Eur J Med Chem; 2018 Sep; 157():705-715. PubMed ID: 30138802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nano-sized Droplets of Self-Emulsifying System for Enhancing Oral Bioavailability of Chemotherapeutic Agent VP-16 in Rats: A Nano Lipid Carrier for BCS Class IV Drugs.
    Khalid N; Sarfraz M; Arafat M; Akhtar M; Löbenberg R; Ur Rehman N
    J Pharm Pharm Sci; 2018; 21(1):398-408. PubMed ID: 30365396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent Development of Copolymeric Nano-Drug Delivery System for Paclitaxel.
    Chen S; Song Z; Feng R
    Anticancer Agents Med Chem; 2020; 20(18):2169-2189. PubMed ID: 32682385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An update of nano-based drug delivery systems for cannabinoids: Biopharmaceutical aspects & therapeutic applications.
    Lazzarotto Rebelatto ER; Rauber GS; Caon T
    Int J Pharm; 2023 Mar; 635():122727. PubMed ID: 36803924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.